Health ❯ Healthcare ❯ Patient Care ❯ Quality of Life

Treatment Outcomes

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

The drug targets chondrosarcoma, a rare bone cancer with no approved therapies.

Small Pediatric Study Links Pazopanib to Improved Two-Year Survival in Metastatic Ewing Sarcoma